How new Insights into ESR1 Mutant Breast Cancers may lead to Novel Therapy Targets

[News]

In this interview, we speak to Steffi Oesterreich, PH.D., from the University of Pittsburgh, about how new insights into a gene mutation present in 20-30% of breast cancer recurrences may have a silver lining, leading to novel treatment opportunities.

More... (https://www.news-medical.net/news/20220509/How-new-Insights-into-ESR1-Mutant-Breast-Cancers-may-lead-to-Novel-Therapy-Targets.aspx)